Quick Answer
Senti Biosciences Holdings, Inc. reported Cash And Cash Equivalents At Carrying Value of $16.42 million for the year ending 2025.
- Senti Biosciences Holdings, Inc. showed a decrease of -66.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Senti Biosciences Holdings, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
- XBRL data for this metric is available from 2021 to 2025 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Historical annual values: Fiscal year 2025: $16.42 million | Fiscal year 2024: $48.28 million | Fiscal year 2023: $35.93 million | Fiscal year 2022: $57.62 million | Fiscal year 2021: $56.03 million | Fiscal year 2021: $0.00.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: